noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

Company News

Colonial River Investments LLC

Initial Quarterly Holdings Report by Institutional Manager (Form 13F-HR)
Truist Financial Corporation

Amendment to Beneficial Ownership Report (Form SC 13G/A)
First Merchants Corporation

First Merchants Deepens Royal Oak Investment with New Downtown Banking[...]

Economy, Business and Finance

Exozymes Inc.

09/11/2026 | Press release | Archived content

BioTuesdays: EXOZ selects Curia as CDMO for NCT

September 11, 2026-

press clippingsNCT

BioTuesdays: EXOZ selects Curia as CDMO for NCT

eXoZymes (NASDAQ: EXOZ) has entered into an agreement with closely held contract research, development, and manufacturing organization (CDMO) Curia Global to initiate technology transfer and scale-up activities for N-transcaffeoyltyramine (NCT).

Full story here...

Exozymes Inc. published this content on September 11, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 19, 2026 at 13:18 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]

Back

View original format